Hood River Capital Management LLC Axsome Therapeutics, Inc. Transaction History
Hood River Capital Management LLC
- $5.4 Billion
- Q3 2024
A detailed history of Hood River Capital Management LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 625,084 shares of AXSM stock, worth $54.2 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
625,084
Previous 549,066
13.84%
Holding current value
$54.2 Million
Previous $44.2 Million
27.07%
% of portfolio
1.04%
Previous 1.08%
Shares
8 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$363 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$346 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$286 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$205 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$90.7 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.72B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...